Certara’s MIDD Oncology Capabilities
Improve Oncology Study Decisions with Certara's MIDD Team Transcript: The pace of oncology drug…
CertaraAugust 7, 2024
Certara Talks: PAGE 2024
Learn more about our Modeling & Simulation Services Transcript: Hello, and welcome to Certara…
CertaraAugust 5, 2024
Certara Talks: ASCPT 2024
Learn more about how our pharmacometricians can help you de-risk your drug development program. Learn…
CertaraMay 31, 2024
Secondary Intelligence™ Demo
Discover how Secondary Intelligence™ can support your compound assessments by predicting off-target activities and potential…
CertaraMay 24, 2024
Explore the World of Endogenous Biomarkers with Simcyp™!
Endogenous biomarkers play a pivotal role in comprehending drug-body interactions, shaping drug development, and propelling…
CertaraApril 26, 2024
Enhancing Regulatory Writing: The Power of Style Guides
Learn more about our Document Quality Services TranscriptMany pharmaceutical industry professionals once considered standardizing regulatory writing style…
CertaraApril 12, 2024
Molecular Glue Drug Development Summit 2024 Recap
Lear more about Quantitative Systems Pharmacology Transcript: Hello, and welcome to Certara Talks. I'm Doctor…
CertaraApril 12, 2024
Supporting the Approval of a Treatment for a Neglected Tropical Disease
In this video, Dr. Mark Sullivan, Managing Director of Medicines Development for Global Health, explains…
CertaraApril 9, 2024
